Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by longconfusedplion Oct 28, 2018 4:15pm
145 Views
Post# 28884688

PBI4050 interactive questions

PBI4050 interactive questionsHi everyone, 

First of all, CRUCIAL question is 4050 would cure the IPF disease or would allow patients to live with the disease?

Sencond, there are already 2 approved drugrs that treat SOMEHOW IPF? but neither of these drugs are able to stop or reverse the loss of lung function due to fibrosis APPARENTLY

Does that mean PLI drug will be better than these 2 already approved? I think YES since they putting full efforts in it

Im trying to understang where we are in the drug dev 4050. I understand phase 2 completed, BUT was it for IPF ONLY or, in metabolic syndrome with type 2 diabetes, in Alstrm syndrome and IPF 

So the approbation they seeking is for IPF all diabetes and Alstrom as well.

Are we in the phase 3 already , whcih is the final phase and how long it should take for the phase to finnish or be completed?

Good day 

fuc)off seriously if you state im a basher or a pumper


Bullboard Posts